How to Treat Autistic Patients with swLORETA Neurofeedback & Neurostimulation

Описание к видео How to Treat Autistic Patients with swLORETA Neurofeedback & Neurostimulation

In part 3 of the Drake Institute’s presentation to the Autism Community in Action (TACA), David Velkoff MD, Co-Founder and Medical Director of the Drake Institute of Neurophysical Medicine explains why swLORETA neurofeedback and neurostimulation help patients improve brain network functioning.

For more information about autism, please subscribe to our Channel, visit our website at https://www.drakeinstitute.com, or contact us at 1-800-700-4233.

Комментарии

Информация по комментариям в разработке